Civitas Therapeutics
A privately-held biopharmaceutical company focused on developing a robust pipeline of inhaled therapeutics with the clinically-proven ARCUS dry powder pulmonary delivery platform. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD300—450m (Dealroom.co estimates Aug 2014.)
Chelsea Massachusetts (HQ)
Authorizing premium user...